Humana Inc (HUM)

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Ticker: HUM
Exchange: NYSE
Sector: Healthcare
Industry: Healthcare Plans
Market cap: $52.09B
52-week range: $163.11 - $456.50

Valuation

Share price: $433.74 (close of Nov 6, 2026)
P/E (TTM): 41.71x
Price to book: 2.76x
Price to free cash flow: 16.60x
Enterprise value: $39.49B
Book value per share: $157.26

Price performance

Period	Change
1 day	+5.33%
5 days	+4.64%
1 month	+7.29%
3 months	+18.11%
6 months	+76.08%
Year to date	+69.34%
1 year	+72.73%
3 years	-10.99%
5 years	-4.34%
10 years	+159.07%
All time	+4,361.33%

Short interest

As of: Oct 15, 2026
Short % of float: 3.47%
Shares short: 3.67M
Days to cover: 1.98
Change since prior report: +31.39%
Source: FINRA consolidated short interest

Members of Congress who disclosed HUM trades

Gilbert Ray Cisneros · Lisa McClain · Julia Letlow · Robert Bresnahan · Alan Armstrong

Super investors holding HUM

Dodge & Cox (Dodge & Cox Funds) · Richard Pzena (Pzena Investment Management) · Ken Griffin (Citadel) · George Soros (Soros Fund Mgmt) · Ray Dalio (Bridgewater Associates)

Profitability and growth

Return on equity: 6.70%
Return on assets: 2.43%
Net margin: 0.92%
Revenue growth: 10.11%
Net income growth: -1.57%
Free cash flow growth: -84.32%

Cash flow and balance sheet

Free cash flow yield (TTM): 6.03%
Current ratio: 1.65x
Net debt to EBITDA: -4.06x

Latest reported year

Period end: Dec 31, 2025
Fiscal year: 2025
Revenue: $129.66B
Net income: $1.19B
Earnings per share: $9.87
Interest expense: $631.00M
Shares outstanding: 120.45M

Income statement by year

Period end	Revenue	Net income	EPS
2025-12-31	$129.66B	$1.19B	$9.87
2024-12-31	$117.76B	$1.21B	$10.01
2023-12-31	$106.37B	$2.49B	$20.09
2022-12-31	$92.87B	$2.81B	$22.20
2021-12-31	$83.06B	$2.93B	$22.79
2020-12-31	$77.16B	$3.37B	$25.47
2019-12-31	$64.89B	$2.71B	$20.20
2018-12-31	$56.91B	$1.68B	$12.24
2017-12-31	$53.77B	$2.45B	$16.94
2016-12-31	$54.38B	$614.00M	$4.11

Margins and returns by year

Period end	Net margin	Return on equity
2025-12-31	0.92%	6.70%
2024-12-31	1.02%	7.34%
2023-12-31	2.34%	15.25%
2022-12-31	3.02%	18.26%
2021-12-31	3.53%	18.21%
2020-12-31	4.36%	24.53%
2019-12-31	4.17%	22.49%
2018-12-31	2.96%	16.56%
2017-12-31	4.55%	24.87%
2016-12-31	1.13%	5.75%

Cash and debt by year

Period end	Cash	Debt
2025-12-31	$19.90B	$12.37B
2024-12-31	$20.43B	$11.14B
2023-12-31	$21.32B	$10.21B
2022-12-31	$18.94B	$9.03B
2021-12-31	$16.59B	$10.54B
2020-12-31	$17.23B	$6.06B
2019-12-31	$15.03B	$4.97B
2018-12-31	$2.34B	$4.38B
2017-12-31	$4.04B	$4.77B
2016-12-31	$3.88B	$3.79B

Free cash flow by year

Period end	Free cash flow	Stock-based compensation
2025-12-31	$375.00M	$241.00M
2024-12-31	$2.39B	$207.00M
2023-12-31	$2.98B	$175.00M
2022-12-31	$3.45B	$216.00M
2021-12-31	$920.00M	$180.00M
2020-12-31	$4.67B	$181.00M
2019-12-31	$4.55B	$163.00M
2018-12-31	$1.56B	$137.00M
2017-12-31	$3.53B	$157.00M
2016-12-31	$1.41B	$115.00M

Dividend history

Most recent payment: Oct 30, 2026
Paid in the last twelve months: $3.54

Payment date	Dividend per share
2026-10-30	$0.89
2026-06-26	$0.89
2026-03-27	$0.89
2025-12-26	$0.89
2025-09-26	$0.89
2025-06-27	$0.89
2025-03-28	$0.89
2024-12-31	$0.89

Investor relations

Past earnings dates

Reported	Fiscal period	EPS estimate
2026-11-06	Sep 2026	-$1.03
2026-07-29	Jun 2026	$6.22
2026-04-29	Mar 2026	$9.97
2026-02-11	Dec 2025	-$4.01
2025-11-05	Sep 2025	$2.91
2025-07-30	Jun 2025	$6.32
2025-04-30	Mar 2025	$9.98
2025-02-11	Dec 2024	-$2.24

Filings and sources

Company website: humana.com
SEC filings: 10-K, 10-Q and 8-K on EDGAR
Earnings calendar: All upcoming reports

Similar companies

Centene Corp (CNC) · Cigna Group (CI) · Molina Healthcare, Inc. (MOH) · Elevance Health, Inc. (ELV) · CVS Health Corp (CVS) · UnitedHealth Group Inc (UNH) · Veeva Systems Inc (VEEV) · HealthEquity, Inc. (HQY)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades